Title: 
Official Title: To require direct-to-consumer advertisements for prescription drugs and biological products to include truthful and not misleading pricing information.
Number of Sections: 2
Source: versions - Introduced in House
Media Type: text/xml

================================================================================

Section 1:
1.Short titleThis Act may be cited as the Plain Prescription Prices Act.

Section 2:
2.Regulating advertisements for prescription drug and biological product prices(a)In generalNot later than one year after the date of the enactment of this Act, the Secretary of Health and Human Services, acting through the Administrator of the Centers for Medicare & Medicaid Services (referred to in this section as the Administrator), shall promulgate regulations requiring each direct-to-consumer advertisement on television (including broadcast, cable, streaming, and satellite television) for a prescription drug or biological product for which payment is available under title XVIII or XIX of the Social Security Act to include a textual statement, which shall be truthful and not misleading, indicating the list price, as determined on the first day of the quarter during which the advertisement is being aired or otherwise broadcast, for a typical 30-day regimen or typical course of treatment (whichever is most appropriate).(b)DeterminationsIn promulgating regulations under subsection (a), the Administrator shall determine—(1)whether such regulations should apply with respect to additional forms of advertising;(2)the manner and format of textual statements described in such subsection;(3)appropriate enforcement mechanisms; and(4)whether such textual statements should include any other price information, as appropriate.


================================================================================

Raw Text:
119 HR 4623 IH: Plain Prescription Prices Act
U.S. House of Representatives
2025-07-22
text/xml
EN
Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain.



I119th CONGRESS1st SessionH. R. 4623IN THE HOUSE OF REPRESENTATIVESJuly 22, 2025Ms. Williams of Georgia (for herself, Mr. Bacon, Ms. Craig, and Mr. Steil) introduced the following bill; which was referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concernedA BILLTo require direct-to-consumer advertisements for prescription drugs and biological products to include truthful and not misleading pricing information.1.Short titleThis Act may be cited as the Plain Prescription Prices Act. 2.Regulating advertisements for prescription drug and biological product prices(a)In generalNot later than one year after the date of the enactment of this Act, the Secretary of Health and Human Services, acting through the Administrator of the Centers for Medicare & Medicaid Services (referred to in this section as the Administrator), shall promulgate regulations requiring each direct-to-consumer advertisement on television (including broadcast, cable, streaming, and satellite television) for a prescription drug or biological product for which payment is available under title XVIII or XIX of the Social Security Act to include a textual statement, which shall be truthful and not misleading, indicating the list price, as determined on the first day of the quarter during which the advertisement is being aired or otherwise broadcast, for a typical 30-day regimen or typical course of treatment (whichever is most appropriate).(b)DeterminationsIn promulgating regulations under subsection (a), the Administrator shall determine—(1)whether such regulations should apply with respect to additional forms of advertising;(2)the manner and format of textual statements described in such subsection;(3)appropriate enforcement mechanisms; and(4)whether such textual statements should include any other price information, as appropriate.